Ripamonti

1.2k papers and 58.5k indexed citations i.

About

In recent decades, authors affiliated with Ripamonti have published 1.2k papers, which have received a total of 58.5k indexed citations. Scholars at this organization have produced 397 papers in Oncology, 257 papers in Molecular Biology and 244 papers in Pulmonary and Respiratory Medicine on the topics of Breast Cancer Treatment Studies (145 papers), Breast Lesions and Carcinomas (65 papers) and Breast Implant and Reconstruction (55 papers). Their work is cited by papers focused on Molecular Biology (21.4k citations), Oncology (16.7k citations) and Cancer Research (9.8k citations). Authors at Ripamonti collaborate with scholars in Italy, United States and Switzerland and have published in prestigious journals including Nature, Science and Cell. Some of Ripamonti's most productive authors include Giuseppe Viale, Patrick Maisonneuve, Pier Paolo Di Fiore, Paolo Veronesi and Peter Boyle.

In The Last Decade

Fields of papers published by authors at Ripamonti

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Ripamonti at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Ripamonti

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Ripamonti. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Ripamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ripamonti more than expected).

Rankless by CCL
2025